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Abstract
Cyclic-di-GMP (c-di-GMP) is a ubiquitous bacterial signaling molecule that regulates a vari-
ety of complex processes through a diverse set of c-di-GMP receptor proteins. We have uti-
lized a systematic approach to identify c-di-GMP receptors from the pathogen Vibrio
cholerae using the Differential Radial Capillary Action of Ligand Assay (DRaCALA). The
DRaCALA screen identified a majority of known c-di-GMP binding proteins in V. cholerae
and revealed a novel c-di-GMP binding protein, MshE (VC0405), an ATPase associated
with the mannose sensitive hemagglutinin (MSHA) type IV pilus. The known c-di-GMP bind-
ing proteins identified by DRaCALA include diguanylate cyclases, phosphodiesterases,
PilZ domain proteins and transcription factors VpsT and VpsR, indicating that the DRa-
CALA-based screen of open reading frame libraries is a feasible approach to uncover novel
receptors of small molecule ligands. Since MshE lacks the canonical c-di-GMP-binding
motifs, a truncation analysis was utilized to locate the c-di-GMP binding activity to the N-ter-
minal T2SSE_N domain. Alignment of MshE homologs revealed candidate conserved resi-
dues responsible for c-di-GMP binding. Site-directed mutagenesis of these candidate
residues revealed that the Arg9 residue is required for c-di-GMP binding. The ability of c-di-
GMP binding to MshE to regulate MSHA dependent processes was evaluated. The R9A
allele, in contrast to the wild type MshE, was unable to complement the ΔmshEmutant for
the production of extracellular MshA to the cell surface, reduction in flagella swimming motil-
ity, attachment to surfaces and formation of biofilms. Testing homologs of MshE for binding
to c-di-GMP identified the type II secretion ATPase of Pseudomonas aeruginosa
(PA14_29490) as a c-di-GMP receptor, indicating that type II secretion and type IV pili are
both regulated by c-di-GMP.
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Author Summary
Cyclic-di-GMP (c-di-GMP) is a ubiquitous bacterial signaling molecule that regulates
important bacterial functions, including virulence, antibiotic resistance, biofilm formation
and cell division. The list of known c-di-GMP receptors is clearly incomplete. Here we uti-
lized a systematic and unbiased biochemical approach to identify c-di-GMP receptors
from the 3,812 genes of the Vibrio cholerae genome. Results from this analysis identified
most known c-di-GMP receptors as well as MshE, a protein not known to interact with c-
di-GMP. The c-di-GMP binding site was identified at the N-terminus of MshE and
requires a conserved arginine residue in the 9th position. MshE is the ATPase that powers
the secretion of the MshA pili onto the surface of the bacteria. We show that c-di-GMP
binding to MshE is required for MshA export and the function of the pili in attachment
and biofilm formation. ATPases responsible for related processes such as type IV pili and
type II secretion were also tested for c-di-GMP binding, which identified the P. aeruginosa
ATPase PA14_29490 as another c-di-GMP binding protein. These findings reveal a new
class of c-di-GMP receptor and raise the possibility that c-di-GMP regulate membrane
complexes through direct interaction with related type II secretion and type IV pili
ATPases.
Introduction
Cyclic diguanosine monophosphate (c-di-GMP) is a ubiquitous bacterial nucleotide secondary
signaling molecule that regulates cellular processes in response to environmental and cellular
stimuli. The elements of this canonical pathway of signal production, signal transduction,
altered activity and signal removal were elegantly described by the Benziman lab over twenty-
five years ago [1, 2]. C-di-GMP is synthesized by diguanylate cyclases (DGCs) via a catalytic
GGDEF domain [1, 3, 4]. Once made in the cell, c-di-GMP binds to macromolecule receptors
to allosterically alter their activities. C-di-GMP signaling is terminated through hydrolysis by
phosphodiesterases (PDEs) that contain catalytic EAL or HD-GYP domains [5–8]. In the char-
acterization of bacterial cellulose synthase in Komagataeibacter xylinus, the Benziman lab dem-
onstrated the importance of c-di-GMP in the allosteric activation of the cellulose synthase
complex [1, 9, 10]. Recent structure elucidation of the BcsA-BcsB-c-di-GMP complex validated
these early finding and provided a molecular mechanism for c-di-GMP activation of cellulose
biosynthesis [11]. Since this initial description of c-di-GMP regulation of cellulose biosynthesis,
genome sequencing has revealed genes for DGCs in diverse bacteria indicating that c-di-GMP
is a ubiquitous and important signaling molecule in prokaryotes that regulates a variety of phe-
notypes [12].
The identification of receptor proteins for c-di-GMP is needed for understanding the regu-
lation by this ubiquitous signaling molecule. However, the process of identifying c-di-GMP
binding proteins has been challenging for several reasons. First, c-di-GMP simultaneously reg-
ulates complex traits including promoting biofilm formation, inhibiting motility and additional
pathways [13–15] indicating that there are likely many c-di-GMP receptors in the cell. Second,
although there are several defined protein domains that bind c-di-GMP (see below), these
domains do not accurately predict c-di-GMP binding proteins. For example, the PilZ domain
binds c-di-GMP [16], but the PilZ protein in P. aeruginosa, for which the domain is named,
does not bind c-di-GMP [17]. In V. cholerae, there are five PilZ domain proteins, but these five
proteins do not fully explain all of the observed c-di-GMP regulated effects [18]. Third, c-di-
GMP binds a number of proteins that do not have predicted binding motifs or were predicted
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to bind a different ligand. Examples of novel c-di-GMP binding proteins include VpsT [19],
VpsR [20] and FlrA [21] in V. cholerae as well as FleQ in P. aeruginosa [22]. In addition, the
Clp protein in Xanthomoas species, a homolog of the cAMP receptor protein (CRP) of E. coli,
binds c-di-GMP rather than cAMP [23, 24]. Another example of a c-di-GMP receptor that was
not predicted is the BldD of Streptomyces coelicolor binds two dimers of c-di-GMP to repress
transcription [25]. Together, these studies reveal the diversity of cellular targets of c-di-GMP
that mediate complex regulation and the highlight the challenges in identifying the c-di-GMP-
binding receptors that are responsible for c-di-GMP regulation.
Many approaches have been utilized to identify c-di-GMP binding proteins. The first pro-
teins shown to bind c-di-GMP included the enzymes that make and degrade c-di-GMP. The I-
site of DGCs binds c-di-GMP to provide product feedback inhibition of DGC activity [4, 26].
Enzymatically active or inactive PDEs are also capable of c-di-GMP binding [5, 27–30]. Bioin-
formatic studies revealed that the PilZ domain is a c-di-GMP binding domain [16]. In addition,
targeted and unbiased approaches have been employed to identify c-di-GMP receptor proteins.
In the targeted approach, genes of c-di-GMP regulated processes were tested for c-di-GMP
binding [19–25, 31, 32]. These studies led to the discoveries of the c-di-GMP receptor proteins
that have not been predicted by bioinformatics and have motivated identification of novel c-di-
GMP receptor proteins using systematic approaches. Affinity pull-down assays using c-di-
GMP conjugated sepharose resin, biotin, or a tripartite c-di-GMP capture compound enriched
c-di-GMP binding proteins from whole cell lysates, which were subsequently identified by
mass spectrometry [33–35]. This approach has also been employed to identify binding proteins
of another prokaryotic cyclic dinucleotide, cyclic-di-AMP (c-di-AMP) [36–38]. An alternative
unbiased approach utilizes the Differential Radial Capillary Action of Ligand Assay (DRa-
CALA) to systematically screen protein expression libraries for ligand binding activity. DRa-
CALA relies on the differential spreading of bound and unbound radiolabeled ligand when
mixed with protein and spotted on a nitrocellulose membrane [39]. In addition, DRaCALA
allowed direct detection of c-di-GMP receptors expressed in E. coli whole cell lysates thus
enabling the screening of individual genes from a target genome [39]. This approach has been
used on Staphylococcus aureus and Escherichia coli open reading frame (ORF) libraries to iden-
tify c-di-AMP and c-di-GMP binding proteins, respectively [36, 40].
Vibrio cholerae was chosen as an organism for a DRaCALA based screen of c-di-GMP bind-
ing proteins since an open reading frame library was available [41] and it is an organisms that
extensively utilize c-di-GMP signaling system to regulate motility, biofilm formation, patho-
genesis, and survival upon dissemination to environmental reservoirs [42–46]. The V. cholerae
O1 El Tor N16961 genome encodes 62 proteins with domains for c-di-GMP metabolism
including 31 GGDEF, 13 EAL, 9 GGDEF+EAL, and 8 HD-GYP domain proteins [47–49].
However, only 5 c-di-GMP receptor proteins have been identified, including 2 PilZ domain
proteins PlzC and PlzD [18], and 3 transcription factors VpsT, VpsR, and FlrA [19–21]. From
the DRaCALA screen of the V. cholerae open reading library, a number of predicted c-di-GMP
binding proteins were identified. In addition, MshE, an ATPase in the mannose sensitive hem-
agglutinin (MSHA) type IV pilus operon, was also revealed as a c-di-GMP receptor. Purified
MshE specifically binds c-di-GMP with a high affinity (Kd approximately 2 μM). Screening of
related type II secretion and type IV pili ATPases identified a gene in P. aeruginosa,
PA14_29490, as a c-di-GMP receptor. Through fragmentation of MshE and site-directed muta-
genesis of the conserved residues, the arginine at position 9 was identified as a residue required
for c-di-GMP binding. Complementation of ΔmshEmutants with wild typemshE restored c-
di-GMP regulation of motility, pilus production, and biofilm formation. In contrast, comple-
mentation withmshE R9A failed to restore c-di-GMP regulation of MshA pilus function.
These results define a novel set of c-di-GMP-binding ATPases associated with type IV pili and
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type II secretion systems and demonstrate the utility of a DRaCALA screen for identification of
c-di-GMP receptor proteins.
Results
DRaCALA screening of a V. choleraeORFeome for c-di-GMP binding
activity
We sought to systematically identify protein receptors of c-di-GMP using DRaCALA by indi-
vidually testing Vibrio cholerae ORFs expressed in E. coli whole cell lysates for 32P-c-di-GMP
binding activity. The 3,812 unique ORFs from the V. choleraeO1 El Tor N16961 ORFeome
pDONR plasmids were recombined into gateway-compatible histidine (His-ORF) or His-malt-
ose binding protein (His-MBP-ORF) expression vectors in a single Gateway reaction [50] and
selected on agar plates containing either carbenicillin or gentamicin, respectively. For each
ORF, multiple transformants were inoculated into a single well of a 96-well microtiter plate to
create His-ORF and His-MBP-ORF libraries from which whole cell lysates were generated.
Protein expression in whole cell lysates was tested for 348 ORFs by PAGE separation and
revealed by staining with Coomassie. A band corresponding to the predicted molecular weight
was visualized for 49% of His-ORF and 76% of His-MBP-ORF fusions for a combined coverage
of 81% of the V. cholerae ORFeome. These results indicate that most V. cholerae proteins are
overexpressed in the His-ORF and His-MBP-ORF libraries, thus enabling a systematic
genome-wide DRaCALA screen for c-di-GMP binding proteins.
Whole cell lysates from His-ORF and His-MBP-ORF libraries were tested for c-di-GMP
binding by DRaCALA using a 96 well pin tool. The fraction bound of 32P-c-di-GMP was mea-
sured in duplicate for each whole cell lysate and positive V. choleraeORFs were defined as
those having c-di-GMP fraction bound three standard deviations above the mean for both
measurements (Fig 1, S1 Table) (see Material and Methods). The positive control expressing
PelD, a known c-di-GMP-binding protein, was above the cutoff in each 96-well plate. This pri-
mary screen identified 55 His-ORF and 47 His-MBP-ORF proteins that significantly increased
the fraction bound of 32P-c-di-GMP. A secondary screen was performed to validate these
ORFs. In total, 23 His-ORFs and 22 His-MBP-ORFs (28 unique ORFs total) were validated as
positive for c-di-GMP binding (Fig 1, Table 1). The specificity for c-di-GMP binding of cell
lysates expressing positive ORFs was determined by competition experiments using unlabeled
guanosine nucleotides (Table 1). Unlabeled c-di-GMP significantly reduced 32P-c-di-GMP
binding for ORFs listed in Table 1. In contrast, unlabeled GTP and cGMP did not reduce 32P-
c-di-GMP binding, suggesting that the measured binding activity was specific for c-di-GMP.
Together these results illustrate how sequential high-throughput DRaCALA screens can iden-
tify genetic elements that encode proteins with specific ligand binding activity. This screen of
the V. choleraeORFeome for c-di-GMP binding proteins identified known and candidate c-di-
GMP receptors.
Positive ORFs encode c-di-GMP binding proteins
The ORFs identified in our DRaCALA-based ORFeome screen included several proteins with
either predicted or demonstrated c-di-GMP binding activity. The list of 28 positive ORFs
include three with GGDEF domains, four with EAL, four with both GGDEF and EAL, six with
HD-GYP, three with PilZ, two encoding known c-di-GMP binding transcription factors, and
six proteins lacking a defined c-di-GMP binding domain (Table 1). Of the proteins containing
only the GGDEF domain, three ORFs identified contain the RxxD motif required for c-di-
GMP binding (VC1370, VC2370, VCA0965 (CdgF)), which is present in only 11 of the 37
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ORFs with GGDEF domains (S1 Fig). Four ORFs (VC0072, VC0658, VC0703 (MbaA),
VC1934) were identified with both GGDEF and EAL domains, but lacking the RxxD motif,
suggesting that c-di-GMP binding occurs at the EAL domain. Both EAL and HD-GYP
domains can bind c-di-GMP as a substrate for hydrolysis. The screen identified four ORFs con-
taining an EAL domain (VC1641, VC1652 (VieA), VC1710, VCA1083) and six ORFs contain-
ing a HD-GYP domain (VC1295, VC1348, VCA0210, VCA0681, VCA0895, VCA0931). The
V. cholerae genome contains 5 ORFs that encode PilZ domains. While four of these (PlzA, -C,
-D, and -E) retain RxxxR and DxSxxG motifs required for c-di-GMP binding, only PlzC
(VC2344) and PlzD (VCA0042) have been demonstrated to bind c-di-GMP biochemically [18,
51]. From the DRaCALA-based ORFeome screen, PlzC and PlzD were identified in both His-
ORF and His-MBP-ORF libraries, while PlzE (VCA0735) was identified only in the His-
MBP-ORF library. Previous work demonstrated c-di-GMP binding for His-fusions of PlzC
and PlzD but not PlzE, suggesting that a MBP fusion to PlzE may be required for proper fold-
ing of the c-di-GMP binding site during heterologous expression of PlzE [52, 53]. Finally, two
of three c-di-GMP binding transcription factors, VpsT (VCA0952) [19] and VpsR (VC0665)
[20] were identified, but not FlrA (VC2137) [21]. In total, DRaCALA identified 22 of 46 (48%)
proteins predicted to bind c-di-GMP and 6 of 11 (55%) proteins previously shown to bind c-
di-GMP (Table 2). These results demonstrate that DRaCALA-based screen can identify all
known categories of c-di-GMP binding proteins and represents an unbiased approach to dis-
covering receptor proteins of signaling molecules.
Six ORFs were identified which encode proteins that are not known or predicted to bind c-
di-GMP, namely VC0405 (MshE), VC1308 (TyrR), VC2066 (FliA), VC2529 (RpoN),
VCA0071 (PstC), and VCA0593 (Table 1). These ORFs represent potentially novel types of c-
di-GMP binding proteins. To determine if these proteins bind c-di-GMP directly, His-
Fig 1. Primary DRaCALA screen of Vibrio choleraeORF libraries. Average fraction bound 32P-c-di-GMP vs. individual V. cholerae (A) His-ORFs and (B)
His-MBP-ORFs overexpressed in E. coli whole cell lysates. ORFs are arranged by VC gene number along the X-axis. ORFs validated as positive in the
secondary screen are indicated by color and classified by type of c-di-GMP-binding protein. “Other” refers to proteins that have not been predicted or
demonstrated to bind c-di-GMP.
doi:10.1371/journal.ppat.1005232.g001
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MBP-ORF fusions were purified and assayed for c-di-GMP binding activity by DRaCALA. C-
di-GMP binding was detected for purified MshE, but not for RpoN, FliA, TyrR, or VCA0593
(S2 Fig). We were unable to purify PstC. These results suggest that heterologous expression of
RpoN, FliA, TyrR, or VCA0593 can induce the expression of c-di-GMP binding proteins
encoded within the E. coli genome. In the remainder of the manuscript, we characterize the c-
di-GMP binding properties of MshE.
Table 1. Specific binding of validated ORFs to c-di-GMP.
His-ORF His-MBP-ORF Protein (c-di-GMP binding
domain)






cGMP GTP NC c-di-
GMP
cGMP GTP
VC0405 0.29 0.07* 0.30 0.39 0.36 0.03 * 0.32 0.38 MshE N/A
VC1308 0.34 0.06* 0.26 0.35 - - - - TyrR N/A
VC2066 - - - - 0.12 0.02 * 0.08 0.12 FliA N/A
VC2529 0.08 0.01* 0.07 0.09 - - - - RpoN N/A
VCA0071 - - - - 0.05 0.02 0.05 0.05 PstC N/A
VCA0593 0.55 0.02 * 0.62 0.61 0.53 0.03 * 0.59 0.57 N/A N/A
VC0665 0.15 0.02 * 0.15 0.14 - - - - VpsR (+) [20]
VCA0952 0.17 0.04 * 0.18 0.24 - - - - VpsT (+) [19]
VCA0042 0.58 0.03 * 0.65 0.61 0.48 0.07 * 0.50 0.52 PlzD (PilZ) (+) [18]
VC2344 0.57 0.04 * 0.61 0.62 0.53 0.03 * 0.55 0.55 PlzC (PilZ) (+) [18]
VCA0735 - - - - 0.28 0.03 * 0.27 0.31 PlzE (PilZ) (+) [18]
VC1370 0.45 0.03 * 0.51 0.47 0.30 0.02 * 0.34 0.37 (GGDEF) N/A
VC2370 0.16 0.04 * 0.20 0.15 0.07 0.04 0.13 0.08 (GGDEF) N/A
VCA0965 - - - - 0.17 0.02 * 0.14 0.13 CdgF (GGDEF) (+) DGC [109]
VC0658 0.55 0.02 * 0.60 0.61 0.56 0.02 * 0.58 0.59 (GGDEF + EAL) N/A
VC0072 0.36 0.00 * 0.49 0.48 0.47 0.02 * 0.51 0.55 (GGDEF + EAL) N/A
VC0703 0.19 0.05 * 0.19 0.23 0.23 0.01 * 0.19 0.20 MbaA (GGDEF + EAL) N/A
VC1934 0.24 0.02 * 0.21 0.22 - - - - (GGDEF + EAL) N/A
VC1641 0.58 0.02 * 0.66 0.63 0.30 0.04 * 0.32 0.36 (EAL) N/A
VC1710 0.42 0.06 * 0.50 0.58 0.42 0.02 * 0.47 0.56 (EAL) N/A
VCA1083 0.57 0.04 * 0.64 0.61 0.53 0.04 * 0.53 0.58 (EAL) N/A
VC1652 0.36 0.08 * 0.47 0.52 - - - - VieA (EAL) (+) PDE [110]
VCA0681 0.51 0.01 * 0.50 0.58 0.50 0.01 * 0.48 0.55 (HD-GYP) (+) PDE [49]
VCA0210 0.17 0.03 * 0.17 0.15 0.33 0.04 * 0.41 0.34 (HD-GYP) N/A
VC1295 0.46 0.02 * 0.55 0.52 0.51 0.02 * 0.55 0.57 (HD-GYP) N/A
VCA0931 0.33 0.01 * 0.36 0.42 0.36 0.02 * 0.41 0.48 (HD-GYP) N/A
VC1348 0.49 0.02 * 0.55 0.52 0.54 0.02 * 0.54 0.56 (HD-GYP) N/A
VCA0895 - - - - 0.28 0.01 * 0.27 0.26 (HD-GYP) N/A
1 Binding and enzymatic activity is deemed positive if activity has been demonstrated for the purified protein or if mutation of residues required for c-di-
GMP binding or enyzmatic activity regulate a c-di-GMP dependent phenotype.
(+) = c-di-GMP binding observed,
DGC = diguanylate cyclase activity observed,
PDE = phosphodiesterase activity observed.
Two-way ANOVA was used to determine if the fraction bound to 32P-c-di-GMP in the presence unlabeled c-di-GMP competitor differed significantly from
no competitor (NC).
* = p < 0.001.
doi:10.1371/journal.ppat.1005232.t001
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Table 2. Hit rate of V. choleraeORFs encoding predicted and previously demonstrated cdiGMP-binding proteins.1
C-di-GMP binding domain Gene number c-di-GMP binding DRaCALA screen
GGDEF (RxxD)2








VCA0697 (CdgD) Predicted Negative
VCA0960 Predicted Negative
VCA0965 (CdgF) Predicted Positive
Total 11 3 (27%)
PilZ (RxxxR. . .DxSxxG)3
VC0697 (PlzA) Predicted Negative
VC2344 (PlzC) Experimentally Demonstrated [18] Positive
VCA0042 (PlzD) Experimentally Demonstrated [18] Positive
VCA0735 (PlzE) Predicted Positive
Total 4 3 (75%)
EAL4
VC0072 Predicted Positive
VC0130 (CdpA) Experimentally Demonstrated [111] Negative
VC0137 (CdgJ) Experimentally Demonstrated [112] Negative
VC0653 Predicted Negative
VC0658 Predicted Positive
VC0703 (MbaA) Predicted Positive
VC1086 Experimentally Demonstrated [113] Negative
VC1211 Predicted Negative
VC1592 (AcgA) Experimentally Demonstrated [114] Negative
VC1641 Predicted Positive








VCA0785 (CdgC) Predicted Negative







VCA0681 Experimentally Demonstrated [49] Positive
(Continued)
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MshE specifically binds c-di-GMP with high affinity
To determine the affinity and specificity of c-di-GMP-binding to MshE, purified His-
MBP-MshE was assayed for binding to 32P-c-di-GMP by DRaCALA. The affinity of c-di-
GMP-binding was determined by quantifying the fraction bound of 32P-c-di-GMP in serial
dilutions of His-MBP MshE (Fig 2A). Non-linear regression analysis of c-di-GMP-binding vs.
protein concentration using a one site-binding model estimated the dissociation constant (Kd)
for c-di-GMP to be 1.9 ± 0.4 μM. To determine the specificity of c-di-GMP-binding to MshE,
we measured the fraction bound of 32P-c-di-GMP in the presence of unlabeled nucleotide com-
petitors. 32P-c-di-GMP-binding to His-MBP-MshE was significantly decreased by unlabeled c-
di-GMP, but not by GTP, GDP, GMP cGMP, ATP, ADP, AMP, cAMP, CTP, or UTP (Fig 2B).
MshE also binds ATP specifically since only ATP and ADP compete for 32P-ATP binding (Fig
2C). These results indicate that MshE specifically binds c-di-GMP with micromolar affinity
and at a site that is distinct from the ATP binding site.
A subset of ATPases that regulate type IV pili and type II secretion
systems bind c-di-GMP
MshE belongs to a family of ATPases associated with the biosynthesis and retraction of type IV
pili and secretion by type II secretion systems. These phylogenetically related ATPases are
called as T2SSE ATPases based on the type II secretion system (T2SS) nomenclature for Gen-
eral secretion protein E (GspE) [54, 55]. To determine if c-di-GMP-binding is a conserved fea-
ture of T2SSE ATPases, we identified homologs of MshE and assayed them for c-di-GMP-
binding. Protein-Blast search with the full-length MshE amino acid sequence against the com-
plete protein sets of V. cholerae O1 El Tor N16961 and P. aeruginosa PA14 identified five addi-
tional ATPases in V. cholerae and nine in P. aeruginosa with an E value< 1x10-15. These
ATPases include those required for type IV pili function: PilB (VC2424 and PA14_58750,)
PilT (PA14_05180 and PA14_59340), PilU (PA14_05190), and TcpT (VC0835); and type II
Table 2. (Continued)
C-di-GMP binding domain Gene number c-di-GMP binding DRaCALA screen
VCA0895 Predicted Positive
VCA0931 Predicted Positive
Total 8 6 (75%)
Transcription Factors
VC0065 (VpsR) Experimentally Demonstrated [20] Positive
VC2137 (FlrA) Experimentally Demonstrated [21] Negative
VCA0952 (VpsT) Experimentally Demonstrated [19] Positive
Total 3 2 (67%)
Total
Overall 46 22 (48%)
Experimental demonstrated 11 6 (55%)
1 Only genes represented in the V. cholerae ORF library are shown.
2 GGDEF containing the RxxD I-site was determined by sequence alignment (S1 Fig) [27].
3 PilZ domains containing the RxxxR. . .DxSxxG were determined by sequence alignment [16][38]. PlzB is omitted since it lacks the RxxxR. . .DxSxxG
motifs.
4 EAL include all proteins containing the EAL domain (PF00563).
5 HD-GYP is defined as described in [60].
doi:10.1371/journal.ppat.1005232.t002
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Fig 2. C-di-GMP bind to MshE ATPase with high affinity, specificity and independently of ATP. (A)
Fraction bound 32P-c-di-GMP to decreasing concentrations of purified His-MBP-MshE. The dissociation
constant (Kd) is indicated. Fraction bound of His-MBP-MshE to (B)
32P-c-di-GMP and (C) 32P-ATP in the
presence of 100 μM nucleotide competitors. P-value was determined by two-tailed t-test (*** p0.001). All
data are average of three independent assays and standard deviation is indicated by error bars.
doi:10.1371/journal.ppat.1005232.g002
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secretion: GspE (VC2732), XcpR (PA14_23990), HxcR (PA14_55440), and HxrA
(PA14_29490) [56–63]. We constructed His-ORF fusions for each V. cholerae and P. aerugi-
nosa T2SSE ATPase and assayed c-di-GMP-binding by DRaCALA in E. coli whole cell lysate
(Fig 3A). Expression of V. choleraeMshE and P. aeruginosa PA14_29490, but not other T2SSE
ATPases, significantly increased the fraction bound of 32P-c-di-GMP. These data identified
MshE and PA14_29490 as c-di-GMP-binding receptor proteins, the only ones among the
T2SSE family in V. cholerae and P. aeruginosa.
PA14_29490 is the reciprocal best BLAST hit for MshE [55]. Based on genomic context,
MshE functions within the MSHA operon [64, 65], while PA14_29490 is encoded within a
putative T2SS operon [66, 67]. Sequence comparison of T2SSE-type ATPases from V. cholerae
and P. aeruginosa showed that they differ substantially in protein length. MshE and
PA14_29490, both 575 aa long, were ~200 aa longer than PilT ATPases VC0462, VC0463,
PA14_05180, PA14_05190, PA14_58760 and PA14_59340. Other T2SSE-type ATPases, anno-
tated as GspE- and PilB-type, ranged in length from 469 to 562 aa, and only PA14_68820 was
the same length as MshE. All these enzymes had very similar C-terminal ATPase domains and
differed primarily in their N-terminal parts, with longer proteins containing an additional
domain, referred to as T2SSE_N (PF05157) domain in the Pfam database [48]. A phylogenetic
tree of the N-terminal fragments of T2SSE_N-containing ATPases showed that MshE is
located in the branch related to PilB ATPases responsible for type IV pili, whereas
PA14_29490 is located in the branch related to GspE ATPases, which participate in type II
secretion (Fig 3B). The canonical PilB and GspE ATPases that were tested (VC2424, VC2732
and their counterparts in P. aeruginosa) belong to branches of the tree that are distinct from
those including MshE and PA14_29490. Expansion of the branches containing MshE (Fig 3C)
and PA14_29490 (Fig 3D) reveal many homologous proteins that may also be receptors of c-
di-GMP. Together, these results suggest that a subset of T2SSE ATPases represented by MshE
and PA14_29490 are c-di-GMP-binding proteins.
PA14_29490 and MshE bind c-di-GMP specifically in the N-terminal
domain
Both MshE and PA14_29490 lack known c-di-GMP binding protein sequence motifs. To
locate the binding site(s) on these proteins, truncation analysis was performed on both pro-
teins. The N-terminal T2SSE_N domain and C-terminal T2SSE ATPase domain of
PA14_29490 and MshE were separated at three points that were predicted to be at the ends of
secondary structural elements (Fig 4A and 4E). These fragments were expressed in E. coli and
the whole cell lysates were tested for c-di-GMP binding. The N-terminal fragments (F1-F3) of
both PA14_29490 and MshE bound 32P-c-di-GMP, while the C-terminal fragments (F4-F6)
did not (Fig 4B and 4F). Purified fragment 1 of PA14_29490 binds c-di-GMP with a Kd of
480 ± 60 nM (Fig 4C) and this binding was competed away only with c-di-GMP (Fig 4D), indi-
cating that binding is specific. Each of the fragments of MshE was purified and tested for bind-
ing to 32P-c-di-GMP. Only the purified N-terminal fragments (F1-F3) of MshE bound 32P-c-
di-GMP, while the C-terminal fragments (F4-F6) did not (Fig 4G). These results indicate that
the binding site for c-di-GMP is located in the N-terminal domain of the protein and is distinct
from the ATPase domain in the C-terminus.
MshE binding to c-di-GMP requires a specific arginine residue
We hypothesized that c-di-GMP regulation of MSHA is an evolutionarily conserved property.
To test this idea, we identified MshE homologs from genomes containing MSHA-like operons
as defined by having themshN gene upstream ofmshE and themshG gene downstream of
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mshE (S3A Fig). ClustalW alignment revealed residues within the first 151 amino acids that are
100% identical among these proteins, including 4 conserved motifs: RLGDLLV, ARRxRAL,
SDPADL, and DxxYRRT (S3B Fig). Since charged residues, in particular arginines, have been
shown to participate in c-di-GMP binding in a variety of receptor proteins, mutant variants
with alanine replacements within these 4 motifs were generated by site-directed mutagenesis
including R9A/D12A, R88A/R89A, D108A/D111A, and R146A/R147A (Fig 5A). As a control,
the conserved E191 and D192 residues, which are located outside of the first 151 amino acid
fragment, were also changed to alanine. Purified R9A/D12A, R88A/R89A, and D108A/D111A
variants were reduced for binding to c-di-GMP, whereas R146A/R147A and E191A/D192A
did not affect binding to c-di-GMP (Fig 5A). These results indicate that motifs 1, 2 and 3 con-
tribute to c-di-GMP binding, while motif 4 is dispensable. The E191A/D192A variant binds c-
di-GMP similarly to the wild-type protein (Fig 5A), in agreement with the results from frag-
ment analysis (Fig 4E). To determine the contribution of each amino acid residue within the
Fig 3. C-di-GMP binds to V. cholerae and P. aeruginosa homologs of MshE. (A) Average fraction bound 32P-c-di-GMP of E. coli whole cell lysate
expressing Vibrio cholerae and Pseudomonas aeruginosa homologs of MshE. The dashed red line indicates background binding for a vector control strain.
All data are average of three independent assays and standard deviation is indicated by error bars. (B) Unrooted phylogenetic tree of the T2SSE_N domain.
Protein sequences present in the tree corresponding to proteins analyzed for c-di-GMP binding are highlighted in green (binds c-di-GMP), red (does not
bind), or blue (candidate binding protein). The dark grey background corresponds to primarily type IV pili PilB sequences, and the light grey background
corresponds to type II secretion protein E ATPase sequences. (C, D) Sub-trees containing VC0405 or PA14_29490 and closely related proteins.
doi:10.1371/journal.ppat.1005232.g003
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first 3 motifs and the other conserved, charged amino acids, we generated and purified MshE
variants with single alanine substitution in positions R9, D12, Q32, E51, R88, R89, D108, D111
and D142 (S4A Fig). The R9A variant had an 83% reduction in c-di-GMP binding, while
Q32A and R88A variants had 61% and 50% reduction, respectively (Fig 5C). Interestingly, the
R9/D12 residues represent an RxxD motif described in DGC I-site [26], PelD [31] and GIL
domain of BcsE [40]. In those proteins, both residues are critical for c-di-GMP binding. In con-
trast, the MshE D12A variant actually binds c-di-GMP better than wild-type MshE (Fig 5C),
Fig 4. C-di-GMP binds MshE and PA14_29490 in the N-terminal T2SSE_N domain. Schematic of the truncations generated in (A) PA14_29490 and (E)
MshE. C-di-GMP binding to E. coli whole cell lysates expressing each fragment of (B) PA14_29490 and (F) MshE. (C) Fraction bound 32P-c-di-GMP to
decreasing concentrations of purified PA14_29490 fragment 1. (D) Fraction bound of purified PA14_29490 fragment 1 to 32P-c-di-GMP in the presence of
100 μM nucleotide competitors. (G) Fraction bound of 32P-c-di-GMP to purified MshE and fragments 1–6. Indicated p-value was determined by two-tailed t-
test (*** p0.001) by comparing the indicated samples. All data are average of three independent assays and standard deviation is indicated by error bars.
doi:10.1371/journal.ppat.1005232.g004
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Fig 5. R9 is required for MshE to bind c-di-GMP. (A) Schematic of the charged and polar conserved
residues in the first 200 amino acids of MshE targeted for site-directed alanine substitution. (B) Fraction
bound of 32P-c-di-GMP to purified MshE (WT) and indicated pairs of alanine substitutions. (C) Fraction bound
of 32P-c-di-GMP to purified MshE (WT) and indicated individual alanine substitution. All data are average of
three independent assays and standard deviation is indicated by error bars.
doi:10.1371/journal.ppat.1005232.g005
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indicating that MshE does not contain an I-site-like binding sequence. Each of these MshE var-
iants was also tested for ATP binding. The R88A variant showed an 88% reduction in ATP
binding and was the only variant that had a reduction by more than 50% (S4B Fig). Thus, the
defect associated with c-di-GMP binding in R88A variant may be due to a general folding
problem for this specific protein. Together, these results indicate MshE contains a novel c-di-
GMP binding site that requires R9 residue with contribution from the Q32 residue.
MshE binding to c-di-GMP enhances ATPase activity
The effect of c-di-GMP on the ATPase activity of MshE was assessed by testing the WTMshE
and the R9A proteins in the presence and absence of c-di-GMP. WTMshE produced 68 μM of
phosphate from ATP without c-di-GMP and increased to 75 and 76 μMwith the addition of
10 and 33 μM of c-di-GMP, respectively (S5 Fig). In contrast, R9A protein produced 60, 64,
and 58 μM of phosphate with addition of 0, 10, and 33 μM of c-di-GMP. These results indicate
that the ATPase activity is increased for WTMshE in response to c-di-GMP at concentrations
above the dissociation constant, while c-di-GMP had no effect on the R9A protein. However,
the magnitude of the enhanced ATPase activity is only about 10% suggesting that c-di-GMP
may have additional effects on MshE interaction with the MshA substrate or other components
of the MSHA export machinery.
C-di-GMP binding to MshE is required for MSHA function in attachment
and biofilm formation
MSHA is a responsible for initial attachment of V. cholerae to surfaces and subsequent biofilm
formation [68]. Recently, MSHA was demonstrated to reduce flagella mediated swimming
motility [69]. We sought to determine whether MshE is the c-di-GMP receptor regulating
MSHA activity by assessing the amount of MshA pili on the bacterial surface, the effect on
swimming motility, and biofilm formation. The effect of MshE on the export of MshA to the
surface of V. cholerae was assessed by surface ELISA using antibodies specific to MshA (Fig 6A,
WT and ΔmshA). The ΔmshEmutant is defective for MshA export (Fig 6A). This defect was
complemented by wild typemshE and the D12A allele, but not the R9A allele (Fig 6A). Com-
plementation with the R88A/R89A allele was able to restore the export of ~10% of MshA
observed in wild type cells. A recent study revealed that V. cholerae swimming motility is
reduced by interaction of MSHA with surfaces [69]. V. cholerae was assessed for motility
through soft agar assay. Wild type V. cholerae had reduced swimming motility and the ΔmshE
mutant has increased motility (Fig 6B, WT and ΔmshE vector) recapitulating previous observa-
tions [69]. The ability of either wild-typemshE ormshE variant under the tac promoter in
trans on a plasmid to complement ΔmshE phenotypes were evaluated. Induction of either allele
that binds c-di-GMP, wild-typemshE or the D12A variant, reduced motility to wild type levels
(Fig 6B). Induction of the variant defective for c-di-GMP binding (R9A) failed to reduce motil-
ity (Fig 6B). The R88A/R89A allele, that had reduced binding to c-di-GMP and ATP, also failed
to reduce motility. Additionally, the requirement for MshE to bind c-di-GMP on biofilm for-
mation was assessed using a flow cell system. At 4 hours post-inoculation, wild-type was able
to attach to the surface, whereas fewer ΔmshEmutants attached to the surface (Fig 6C). Com-
plementation of ΔmshEmutants with wild typemshE and the D12A allele restored attachment,
whereas complementation with either R9A or R88A/R89A allele did not (Fig 6C). At 24 hours
post-inoculation, the initial differences in attachment were more pronounced. Wild type and
ΔmshEmutant complemented with eithermshE or D12A formed mature biofilm (Fig 6D).
Complementation with the R88A/R89A allele also restored biofilm formation indicating a
small amount of surface MshA can restore MSHA activity. In contrast, the ΔmshEmutant
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Fig 6. MshE interaction with c-di-GMP is essential for MSHA function. (A) Surface MshA pilin production under varying IPTG induction determined via
ELISA with MshA-specific antibody. Two biological replicates were assayed in duplicate and normalized to the average of the WT strain with vector. (B)
Expression ofmshE reduces motility in soft agar. The diameters of migration zones were measured after 16 hours of growth at 30°C with or without IPTG
induction and normalized to the motility of the WT strain harboring the empty vector. Three biological replicates were performed in duplicate. Induced strains
were compared to uninduced strains with ANOVA followed by Bonferroni Multiple Comparison test. (** p0.01, *** p0.001). (C) Attachment phenotypes
observed with confocal microscopy 4 h post inoculation in a flow cell system. Scale bar represents 40μm. (D) Three-dimensional biofilm structures observed
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complemented with R9A showed small patches of biofilms similar to ΔmshE with the vector
control (Fig 6D). Quantification of the biofilms revealed that both biomass (Fig 6E) and surface
coverage (Fig 6F) are reduced for ΔmshE complemented with R9A. Together, these results indi-
cate that the ability of MshE to bind c-di-GMP via the R9 residue is required for MshA export
to the cell surface and MSHA-mediated phenotypes.
Discussion
Evaluation of DRaCALA ORF screens for identification of ligand binding
proteins
DRaCALA screens are a relatively new method for identifying ligand binding proteins that
combines arrayed protein libraries with a high-throughput biochemical assay of protein-ligand
interactions. Two recent publications have successfully used DRaCALA screening to identify
novel cyclic-dinucleotide protein receptors. A screen for c-di-AMP binding proteins in the
Staphylococcus aureus strain COL ORFeome identified PstA and KdpD [36]. The screen also
identified KtrA, which was the only protein identified by affinity pull-down using c-di-AMP
magnetic beads in the same study [36]. The crystal structures of PstA-c-di-AMP [70–72] and
KtrA-c-di-AMP complexes [73] have been solved. KdpD binding motif has been recently iden-
tified [74]. Since the DRaCALA screen, one other additional c-di-AMP receptor has been iden-
tified in Gram-positive bacteria, pyruvate carboxylase of Listeria monocytogenes [38]. The S.
aureus pyruvate carboxylase has different residues within the binding motif than the L.mono-
cytogenes and does not bind c-di-AMP [38]. Together these studies demonstrate that DRa-
CALA was able to identify three novel bona-fide c-di-AMP receptors and correctly not detect a
protein that does not bind c-di-AMP. Additionally, a DRaCALA screen for c-di-GMP binding
proteins in the E. coli K12 ASKA overexpression gene library revealed three clones overexpres-
sing putative c-di-GMP binding proteins: BcsE, IlvH and RimO [40]. Of these, BscE was fur-
ther characterized and shown to contain a novel c-di-GMP binding domain, which the authors
named GIL [40]. In conjunction with the results from these screens, our identification of MshE
as a c-di-GMP receptor important for MSHA pilus function in V. cholerae demonstrates that
DRaCALA is a powerful approach for finding new small-molecule receptors across different
bacterial species.
The results of these three DRaCALA screening experiments allow us to further assess the
limitations of the screen. Our screen of the V. cholerae ORFeome identified many, but not all,
of the expected binding proteins. These false negatives could be due to several factors. First, the
enzymatic activity of these proteins may prevent detection. Phosphodiesterases active in the
assay conditions could degrade the 32P-c-di-GMP probe prior to application on nitrocellulose,
while active diguanylate cyclases could produce excess c-di-GMP to compete for binding with
the subsequently added 32P-c-di-GMP probe. The failure to detect binding in many EAL and
GGDEF domain proteins in our screen, as well as the lack of binding detected for all I-site-con-
taining GGDEF proteins assayed in the E. coliDRaCALA screen [40], could be due to these fac-
tors. Second, poor expression of the ORF can result in a false negative because DRaCALA relies
on the expression of proteins above the Kd. In our assay of protein expression, we found that
only a subset of the ORFs tested had a protein band of the correct size on SDS-PAGE. Similarly,
some false negatives of c-di-GMP binding proteins in the E. coli screen were due to poor pro-
tein expression as detected by protein band intensity on SDS-PAGE [40]. Third, the DRaCALA
with confocal microscopy 24 h post inoculation in a flow cell system. Scale bar represents 40μm. (E,F) COMSTAT quantitative analysis of biomass and
surface coverage of biofilms from (D). Three images from each of two independent experiments were analyzed.
doi:10.1371/journal.ppat.1005232.g006
Identification of MshE as a C-di-GMP Receptor from Vibrio cholerae
PLOS Pathogens | DOI:10.1371/journal.ppat.1005232 October 27, 2015 16 / 29
screen interrogates binding of individually expressed ORFs within a heterologous system. Thus
proteins that require endogenous binding partners or activating factors to interact with ligand
may not be active. Our screen also yielded false positives, which could be due to two factors.
First, the expression of proteins that can activate the production of c-di-GMP binding proteins
encoded in the E. coli genome can result in a positive signal. Second, the statistical method uti-
lized to identify “positive” fraction bound may falsely identify proteins whose fraction bounds
are near the cutoff, as was likely the case for Adk, a false positive result in the S. aurus c-di-
AMP screen [36]. Both these categories of false positives can be detected after re-assaying bind-
ing with purified protein.
We suggest several methods to increase the fidelity of DRaCALA-based screens: 1. Testing
the ORFs with multiple fusion proteins can increase the likelihood of overexpressing recombi-
nant proteins that retain ligand binding activity, 2. Express the ORFeome in a strain genetically
modified to remove endogenous c-di-GMP signaling components and thus reduce the likeli-
hood of false positives [75, 76], and 3. Alter the buffer used to resuspend lysates—in the case of
EAL domain PDE-As, resuspension in a buffer containing Ca2+ rather than Mg2+ can inhibit
the activity of PDE-As [2] and increase the likelihood of detecting proteins that degrade c-di-
GMP. Although DRaCALA did not identify all c-di-GMP proteins in the V. cholerae genome,
DRaCALA is an unbiased approach that allows discovery of novel receptor protein such as
MshE. We believe DRaCALA-based approach can be a powerful tool for the discovery of novel
receptor proteins of other small nucleotide signaling molecules.
MshE is the founding member of a new class of c-di-GMP receptor
The MshE is a bona fide c-di-GMP binding protein was demonstrated by 1. High affinity bind-
ing with the Kd of 1.9 μM, 2. High specificity of binding based on competition assays, 3. A
defined binding site located in the N-terminal T2SSE_N domain and 4. The requirement of the
conserved R9 residue for c-di-GMP binding in vitro and for MSHA function in vivo. MshE
represents a new category of c-di-GMP binding proteins since it lacks any of the previously
defined c-di-GMP binding domains (DGC I-sites, EAL, HD-GYP, PilZ or GIL) and is the first
T2SSE ATPase demonstrated to bind c-di-GMP. The conserved R9 and D12 residues are remi-
niscent of the RxxD c-di-GMP binding motif present in the I-site of DGCs or the RxGD bind-
ing motif present in GIL domains. For both DGC I-sites and GIL domains, the R and D
residues are required for c-di-GMP binding. In contrast, MshE requires only the R9 residue for
binding to c-di-GMP, while the D12 residue of MshE is dispensable. In addition to MshE, only
one other type II secretion/type IV pili ATPase, PA14_29490 from P. aeruginosa, bound c-di-
GMP. Other members of this subfamily likely will also have the ability to bind c-di-GMP,
including XpsE from X. campestris (Fig 3B, blue line). In contrast, related ATPases including
PilT and PilU are unlikely to be regulated by c-di-GMP since they are shorter and lack the
T2SSE_N domain. Although MshE and PA14_29490 both bind c-di-GMP in the N-terminal
T2SSE_N domain, their sequence conservation within this domain is quite low. Nonetheless,
proteins containing the T2SSE_N domain should be investigated for their ability to interact
with c-di-GMP (Fig 3B, 3C and 3D).
Predicted structure of the c-di-GMP binding fragment of MshE
Two T2SSE_N domain of T2SSE ATPases have been structurally characterized including N-
terminal fragment of V. cholerae GspE (Protein Data Bank (PDB) entry 2BH1_X) [77] and a
related domain from Xanthomonas campestris (PDB: 2D27, 2D28) [78]. Sequence alignment
the N-terminal 151-aa fragment of MshE to PA14_29490, V. cholerae GspE and X. campestris
GspE by the Conserved Domain Database [79] revealed that the V. cholerae GspE lacks the R9
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and Q32 residues. However, these residues were conserved in the GpsE/XpsEN domain from
X. campestris (S6A Fig). Remarkably, the X. campestris XpsEN was crystallized in two different
forms that reflect two distinct conformational states that differ in the position of two N-termi-
nal helices [78], which include the R9 and Q32 residues (S6B Fig). In one of the structures
(PDB: 2D27), R9 and Q32 are positioned within a reasonable distance from each other and,
upon the rotation of first helix, could form a potential c-di-GMP-binding site (S6B Fig). In the
other structure (PDB: 2D28), the region around Q32 proved so flexible that the exact position
of Q32 could not be resolved [78], which is consistent with the ability of this residue to move
around and participate in ligand binding. Such flexibility has also been observed in the binding
sites of PilZ-containing c-di-GMP receptors [18, 51]. The conformational change of the two N-
terminal helices of MshE upon binding c-di-GMP has the potential to alter its activity. Thus,
type II secretion/type IV pili ATPases with the conserved arginine and glutamine residues cor-
responding to R9 and Q32 of MshE represent candidate c-di-GMP receptors (S6B Fig).
Implications of MshE binding to c-di-GMP in the regulation MSHA during
the V. cholerae infection cycle
V. cholerae cycles between environmental reservoirs and human infections in part using two
type IV pili, MSHA and Tcp. MSHA contributes to the V. cholerae infection cycle by maintain-
ing an environmental reservoir through attachment to chitin surfaces [80, 81] and tolerance to
environmental hypotonic stress [82] through biofilm formation [83]. Upon entry into the next
host, the preformed biofilms protect V. cholerae from lower pH [84] and bile [85]. Subsequently,
V. cholerae express toxin co-regulated pili (Tcp) to promote colonization [86, 87] while concom-
itantly turning off MSHA [88]. The repression of MSHA within the host is critical since a strain
with themsha promoter replaced with the constitutive Plac promoter was outcompeted by the
wild type strain in an infant mouse infection model [88]. This defect can be attributed to binding
of secretory IgA directly to MSHA since these strains do not show a competitive difference in
mice lacking IgA [88] indicating that repression of MSHA during infection is a necessary for
immune evasion. Based on recombination-based in vivo expression technology (RIVET) studies
[46], tcpA is transcribed while themsh operon is repressed early in the infection; in contrast, the
expression pattern is reversed at the late stage of infection. The decrease inmsh transcription
early in the infection is likely regulated in part by the reduced levels of c-di-GMP since several
DGCs are not expressed until late in the infection [46]. However, the precise mechanism for reg-
ulation of the c-di-GMP signal is subject to strain specificity [49, 89] and changes in the host
microenvironment. Another mechanism to reciprocally regulate Tcp andMSHA is from the
TcpJ pre-pilin peptidase. TcpJ has the unique property of processing both TcpA [90] and MshA
[91], but cleavage of MshA by TcpJ leads to rapid degradation [91]. Our finding that MshE
binding to c-di-GMP is required for MSHA production and function adds another mechanism
to enhance the switch between Tcp andMSHA pili. Upon entering the host, the c-di-GMP levels
are reduced, thus reducing both transcription of themsh operon and the function of existing
export machinery to export MshA. In combination with the degradation of newly synthesized
MshA by TcpJ, V. cholerae can quickly change from the immunogenic MSHA to the adhesive
Tcp in the host. Late in the infection, this regulation is reversed allowing the bacteria exiting the
host to express MSHA instead of Tcp to prepare for the environment.
Implications of MshE on c-di-GMP regulation of type IV pili and type II
secretion systems
Binding of MshE to c-di-GMP activates MSHA dependent phenotypes including 1. Production
of MshA pili to the cell surface, 2. MSHA reduction of flagella motility, 3. Adherence to
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surfaces and biofilm formation. These studies show that all of these effects are lost in themshE
R9Amutant that is defective in binding to c-di-GMP. The implication of our results is that c-
di-GMP binding to MshE is required for its activity in polymerizing MshA. This finding is
intriguing since several type IV pili are regulated by c-di-GMP through different mechanisms.
In both Xanthomonas and Pseudomonas spp., type IV pili are regulated by PilZ and FimX pro-
teins [92–95]. However, the precise mechanisms of regulation appear to be different. In X. axo-
nopodis citri and X. campestris, PilZ binds FimX and the PilB ATPase, a homolog of MshE, to
form a tripartite regulatory complex, but these interactions are not conserved in P. aeruginosa
[94, 96, 97]. In addition to regulating the PilB ATPase, c-di-GMP interacts with a second PilZ-
domain protein XC_2249 to regulate interactions the PilT and PilU retraction ATPases in X.
campestris [98]. These studies and our MshE results indicate that c-di-GMP regulates type IV
pili ATPases through a number of different mechanisms. The ability of PA14_29490 to bind c-
di-GMP indicates that there may be also complex regulation of type II secretion systems by c-
di-GMP.
Sustained sensing of c-di-GMP through multi-tiered regulation
C-di-GMP regulates major lifestyle changes in response to altered environmental cues. These
changes incur a high cost in expenditure of cellular resources as well as an opportunity cost of
committing to a sessile lifestyle. There is an emerging pattern in which c-di-GMP regulates the
same phenotype at the transcriptional and post-translational levels. Examples of this include
Pel polysaccharide synthesis in P. aeruginosa [31, 99], and nowMSHA in V. cholerae [100].
The idea of regulation by c-di-GMP first to activate gene expression and later to activate pro-
tein function can be thought of as “sustained sensing”. Sustained sensing enables bacteria to
repeatedly assess environmental and cellular conditions through multi-tiered regulation, and
has been previously described for responses to iron availability, oxidative stress, and other sig-
nals [101, 102]. The concept of sustained signaling applied to c-di-GMP enables prediction of
additional c-di-GMP receptors. In addition to known examples, there are additional c-di-
GMP-regulated processes that could be regulated by sustained sensing. These include two clas-
ses: 1. Operons that are transcriptionally regulated by c-di-GMP, but lack known c-di-GMP
receptor proteins and 2. Operons that encode c-di-GMP receptor proteins, but lack known c-
di-GMP transcriptional regulation. Examples of the first class include a number of biosynthetic
operons of extracellular polysaccharides, such Vps and Eps in V. cholerae [19, 100, 103], Psl in
P. aeruginosa [22], xagABC in X. campestris [32, 104], and Bcam1330-Bcam1341 in Burkhol-
deria cenocepacia [105]. These operons also likely encode a c-di-GMP binding protein to regu-
late polysaccharide biosynthesis at the post-translational level. Examples of the second class
include cellulose synthesis in E. coli [40], the alginate biosynthesis operon in P. aeruginosa [17]
and the large adhesin protein (Lap) of P. fluorescens [28]. Furthermore, c-di-GMP can also
bind to riboswitches [106, 107] to provide another regulatory tier in sustained sensing. There-
fore, based on the emerging theme of sustained sensing of c-di-GMP through multi-tiered reg-
ulation, we suggest that newly discovered processes regulated by c-di-GMP either
transcriptionally or post-translationally be investigated for additional levels of c-di-GMP
control.
Materials and Methods
Gateway destination vector construction
pVL791 Cb GW and pVL847 Gn GW were constructed as destination vectors in LR reactions
(Life Technologies) for cloning VC ORFs. pVL791 Cb and pVL847 Gn are pET-19 derivatives
that are carbenecillin or gentamycin resistant and produce N-terminal His- and His-MBP
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fusions respectively. The gateway destination cassette was amplified from pRFA and cloned in
frame with the N-terminal fusions to produce the gateway adapted vectors.
His-ORF and His-MBP-ORF expression library construction
The V. cholerae N16961 ORF library was obtained from BEI. LR Clonase reactions were per-
formed per NEB protocol using miniprepped pDONR vectors from the V. cholereaORFeome
in combination with pVL791 Cb GW and pVL847 Gn GW destination vectors. Gateway reac-
tions were transformed into an E. coli T7IQ strain (NEB) and recombinants were selected on
LB agar plates containing either carbenecillin or gentamycin. Multiple colonies from individual
transformations were inoculated in LB M9 rich media in 96-well plate format and grown over-
night with shaking at 30°C. Overnight cultures were subcultured 1:50 into fresh media and
grown for 4 hours at 30°C with shaking. Protein expression was induced by addition of 1 mM
IPTG and cultures were grown for an additional 4 hours after induction. 1.5 mL of induced cul-
ture was centrifuged and cells were resuspended in 150 μL of c-di-GMP-binding buffer supple-
mented with 10 μg / mL DNAse, 250 μg / mL Lysozyme and 1 μM PMSF. 20 μL aliquots were
transferred to 96-well microtiter plates and stored at -80°C.
DRaCALA
Whole cell lysates for DRaCALA screening were prepared by freeze-thawing resuspended cells
in microtiter plates a total of 3 times. After the final thaw, 20 μL of c-di-GMP-binding buffer
supplemented with 16 pM 32P-c-di-GMP and 500 mM unlabeled GTP was added to whole cell
lysate plates or purified proteins. 2 μL of this mixture was then spotted in duplicate on nitrocel-
lulose using a 96-well pin tool. DRaCALA of purified proteins was performed with concentra-
tions of protein and unlabeled competitor as indicated. Spots were allowed to dry completely
(about 20 minutes) before exposing a phosphorimager screen and capturing with a Fujifilm
FLA-7000. Photostimulated luminescence (PSL) from the inner spot and total PSL of the spot
were quantitated with Fuji Image Gauge software. The fraction bound was calculated using
measurements of the total area (Aouter), the area of the inner circle (Ainner), the total PSL inten-
sity (Itotal), and the inner intensity (Iinner) as described [39]. DRaCALA was also used to deter-
mine the ability of purified MshE and variants to bind c-di-GMP. Dissociation constants were
estimated assuming a one-site binding model by a nonlinear regression of protein concentra-
tion and fraction bound where, Fraction bound = (Maximum possible Fraction Bound)  [pro-
tein concentration] / (Kd + [protein concentration]).
Identification of positive V. choleraeORFs in primary and secondary
DRaCALA screens
In the primary screen of His-ORF and His-MBP-ORF libraries, mixtures of whole cell lysate
and radiolabeled 32P-c-di-GMP were spotted twice. To identify DRaCALA spots with signifi-
cantly increased fraction bound 32P-c-di-GMP, a positive cutoff three standard deviations
above the mean fraction bound was created for each 96-well plate of whole cell lysates. Positive
spots were iteratively removed from calculations of mean and standard deviation for individual
plates, thereby decreasing the positive cutoff until no additional positives were identified. His-
ORFs and His-MBP-ORFs for which both DRaCALA spots had positive binding were defined
as positive and subjected to a secondary screen. Additionally, 8 His-ORF and 8 His-MBP-ORFs
with only 1 DRaCALA spot with positive binding were also included in the secondary screen,
but none of these ORFs were positive for c-di-GMP binding in the secondary screen.
For each primary positive His-ORF and His-MBP-ORF, 8 whole cell lysates were generated
from individual clones that were isolated from the pooled transformants used to create the
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His-ORF and His-MBP-ORF libraries. Each His-ORF and His-MBP-ORF lysate was spotted
twice by DRaCALA and individual lysates were compared to a set of 8 lysates generated from
vector controls. Positive fraction bound 32P-c-di-GMP for DRaCALA spots was defined as
those with at least 2 fold increase above the average fraction bound for the set of plate-matched
vector controls. Additionally, each lysate was assayed by PCR to verify the size of the inserted
ORF. Positive ORFs from this secondary screen displayed positive fraction bound 32P-c-di-
GMP for both DRaCALA spots created from PCR positive lysates.
Generation of phylogenetic tree
Protein sequences corresponding to COG2840 were obtained from the EggNOG 4.1 database.
Each sequence aligned to Pfam Family PF05157 (Type II Secretion System, protein E, N-termi-
nal domain) using the version 10 HMMwith HMMer 3.1 and the subsequences corresponding
to the T2SSE N-terminal domain were extracted. The remaining 1437 domain sequences were
aligned using the MAFFT 7.157b E-INS-i algorithm and trimmed using TrimAl 1.4 to elimi-
nate columns with more than 90% gaps. An unrooted phylogenetic tree was constructed using
FastTree 2.1.8.
Strains and plasmids
Strains used are listed in S2 Table. Plasmids are listed in S3 Table.
Generation of MshE fragments and site-directed alanine substituted
variants
Fragments of MshE and PA14_29490 were generated using the primers indicated in S4 Table.
Site-directed alanine substitutions of MshE were generated by PCR amplification with the indi-
cated primers, DpnI digest and transformation into E. coli DH5α. pVL791-MshER88A,
pVL791-MshER89A, pVL791-MshED111A were generated using the primers indicated in S3
Table and the NEB Q5 Site-Directed Mutagenesis Kit. All constructs were verified by DNA
sequencing.
Protein expression and purification
V. choleraeMshE and variants were purified as previously described [39]. Briefly, E. coli T7Iq
strains or E. coli BL21(DE3) containing expression plasmids were grown overnight, subcul-
tured in fresh media and grown to OD600~1.0 when expression was induced with 1 mM IPTG.
Induced bacteria were pelleted and resuspended in 10 mM Tris pH 8, 100 mMNaCl, 25 mM
imidazole and frozen at -80°C until purification. Proteins were purified over a Ni-NTA column
and eluted with 10 mM Tris pH 8, 100 mMNaCl, 250 mM imidazole. Purified proteins were
exchanged into 10 mM Tris pH 8, 100 mMNaCl using Sephadex G25. Proteins were aliquoted,
and frozen at -80°C until use.
Plate motility assay
Motility plates consist of LB containing 0.3% agar supplemented with 20μg/mL ampicillin and
25 or 100μM IPTG where appropriate. Plates were poured and allowed to dry at room temper-
ature for 4 h prior to inoculation. Colonies from overnight LB agar plates grown at 30°C were
transferred to motility plates and incubated for 16 h at 30°C. Motility diameter was measured
and normalized to the average of WT on each plate. Experiments were performed with three
biological replicates in triplicate and data were analyzed with a Oneway ANOVA followed by
Dunnett’s multiple comparison test.
Identification of MshE as a C-di-GMP Receptor from Vibrio cholerae
PLOS Pathogens | DOI:10.1371/journal.ppat.1005232 October 27, 2015 21 / 29
Confocal laser scanning microscopy (CLSM) and flow cell biofilm studies
Inoculation of flow cells was done by diluting overnight-grown cultures to an OD600 of 0.04
and injecting into a μ-Slide VI0.4 (Ibidi, Martinsried, Germany). To inoculate the flow cell sur-
face, bacteria were allowed to adhere at room temperature for 1 h. Flow of 2% v/v LB (0.02%
tryptone, 0.01% yeast extract, 1% NaCl; pH 7.5) containing 20μg/mL ampicillin and 100μM
IPTG was initiated at a rate of 7.5 ml/h and continued for 24 h. Confocal images were obtained
on a Zeiss LSM 5 PASCAL Laser Scanning Confocal microscope. Images were obtained with a
40X dry objective and were processed using Imaris (Bitplane, Zurich, Switzerland). Quantita-
tive analyses were performed using the COMSTAT software package [108]. Statistical signifi-
cance was determined using Oneway ANOVA with Dunnett’s Multiple Comparison test. Two
biological replicates were performed in triplicate. Images presented are from one representative
experiment.
Surface pilin ELISA
Surface pili composed of MshA were quantified using an ELISA based on a previously pub-
lished protocol [92]. Briefly, overnight culture was diluted 1:100 in fresh LB medium and
grown to OD600 0.5 at 30°C. Cells (125μL) were added to a 96-well plate (Greiner Bio-One,
Monroe, NC) and incubated at 30°C for one hour. Cells were fixed with 100μL of methanol for
10 minutes at room temperature, then washed twice with PBS. Samples were blocked in 5%
nonfat dry milk and immunoblotted with polyclonal rabbit anti-MshA (1:1000 dilution, gift of
J. Zhu) and horseradish peroxidase (HRP)-conjugated secondary antibody (Santa Cruz Bio-
technology, Santa Cruz, CA). After three washes in PBS, 100μL of TMB (eBioscience, San
Diego, CA) was added and incubated for 30 minutes at room temperature followed by the addi-
tion of 100μL of 2N H2SO4. Absorbance was recorded at 490nm and the samples were normal-
ized to the change in WT. Two biological replicates were assayed in duplicate and statistical
significance was determined with a Oneway ANOVA followed by a Dunnett’s Multiple Com-
parison test.
Protein purification
E. coli BL21 harboring plasmids for gene expression were grown to an OD600 of 0.4 at 30°C in
LB containing 100μg/mL ampicillin. Cultures were shifted to 18°C and IPTG was added to a
final concentration of 100μM. 16h post induction, cells were harvested by centrifugation at
10,000 x g for 15 minutes and stored at -80°C. Cell pellets were resuspended in GST Lysis
Buffer (25mM Tris pH 8.0, 0.5M NaCl containing PI cocktail tablets (Roche Life Science, India-
napolis, IN). Cells were lysed by sonication and cell lysate was cleared via centrifugation.
Cleared lysate was loaded onto GS4B resin and washed with five column volumes of lysis
buffer. Protein was eluted from the resin in 5mL elution buffer (25mM Tris pH8.0, 0.25M
NaCl, 10mM glutathione). Samples were dialyzed against buffer (25mM Tris-HCl, 150mM
NaCl, 250μMDTT, pH 7.5) overnight using 12 kDa cutoff dialysis tubing (Fisherbrand, Pitts-
burgh, PA) and concentrated to approximately 1mL using an Amicon 10KDa cutoff spin filter
(EMDMillipore, Darmstadt, Germany). An aliquot of dialyzed protein was diluted in 6M gua-
nidinium HCl and concentration determined via A280.
ATPase assay
ATPase activity of purified proteins was determined by measuring the production of inorganic
phosphate from ATP using the Enzchek Phosphate Assay Kit (Invitrogen). The standard reac-
tion mixture was prepared with the addition of 2mMMgCl2, 10mM KCl, and 1mM DTT.
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Purified protein in buffer (25mM TrisHCl pH 7.5, 100mMNaCl) was added to the standard
reaction mixture to a final concentration of 1μMwith the indicated concentration of c-di-
GMP. After a 10 minute incubation at room temperature, ATP was added to a final concentra-
tion of 10mM and reactions were incubated at 22°C for 30 minutes. Production of inorganic
phosphate was monitored by reading OD360 and compared to a standard curve of solutions of
KH2PO4. The experiment was performed in triplicate. Significance was determined via
ANOVA and Bonferroni test.
Supporting Information
S1 Fig. Alignment of V. cholerae GGDEF domains. V. cholerae proteins which encode a
GGDEF domain were aligned by Clustal-W. C-di-GMP binding was predicted by the presence
of an RxxD motif (underlined in red) and DGC activity was predicted by the presence of a
GGDEF motif (underlined in black). The presence of protein-encoding ORFs in the V. cholerae
ORF library, potential c-di-GMP binding domains, prediction of activity, protein names, V.
cholerae ORF numbers, and residues comprising the GGDEF domain are indicated. VCA0560
encodes 2 GGDEF domains.
(PDF)
S2 Fig. Testing c-di-GMP binding to purified ORFs identified in the DRaCALA screen that
lack known c-di-GMP binding domains. (A) Purified MBP-FliA (VC2066), MBP-RpoN
(VC2529), MBP-TyrR (VC1308), and MBP-VCA0593 were separated on a 12% PAGE and
stained with Coomassie Brilliant Blue. (B) 32P-c-di-GMP binding to purified MBP-FliA
(VC2066), MBP-RpoN (VC2529), MBP-TyrR (VC1308), and MBP-VCA0593. All data are
average of three independent assays and standard deviation is indicated by error bars.
(EPS)
S3 Fig. Conserved amino acids in MshE revealed by BLAST-P and ClustalW alignment. (A)
BLAST-P scores for proteins most homologous to MshN, MshE and MshG. The genus and
species and the scores for each gene are indicated. The maximum score is for V. cholerae. (B)
ClustalW alignment of the first 237 amino acids of MshE homologs is shown. Amino acids
shaded in gray are 100% identical in all homologs. Asterisks indicate charged and polar resi-
dues targeted with site-directed mutagenesis. Position 151 indicates the C-terminus of Frag-
ment 1 that retains c-di-GMP binding activity.
(EPS)
S4 Fig. Purification of MshE point mutants and their ability to bind 32P-ATP. (A) Purified
MshE and variants with indicated single alanine substitution were separated on a 12% PAGE
and stained with Coomassie Brilliant Blue. (B) 32P-ATP binding to purified MshE and variants
with indicated single alanine substitution. All data are average of three independent assays and
standard deviation is indicated by error bars.
(PDF)
S5 Fig. MshE binding to c-di-GMP enhances ATPase activity. ATPase activity of WTMshE
and R9A proteins was assessed by detecting free phosphate released using the EnzCheck phos-
phate assay in the presence of 0, 10 and 33 μM c-di-GMP. Each condition was assayed with
three independent reactions. Statistical analyses were performed using ANOVA followed by
Bonferroni Multiple Comparison test. ( p<0.01).
(PDF)
S6 Fig. Positions of c-di-GMP-binding residues in MshE sequence and structure. (A)
Sequence alignment of the N-terminal fragment of Vibrio choleraeMshE (VC0705) with
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PA14_29490 from Pseudomonas aeruginosa, GspE proteins from Xanthomonas campestris
(UniProt: GPSE_XANCP, PDB: 2D27) and V. cholerae (GPSE_VIBCH, PDB: 2BH1). (B)
Structure of the N-terminal domain of GSPE_XANCP (PDB: 2D27), Arg9 and Gln32 are
shown in stick representation.
(PDF)
S1 Table. Fraction bound of 32P-c-di-GMP from primary DRaCALA screen of V. cholerae
ORF library.
(PDF)
S2 Table. Strains used in this study.
(PDF)
S3 Table. Plasmids used in this study.
(PDF)
S4 Table. Primers used in this study.
(PDF)
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